Sanoculis offers a new alternative surgical procedure for treating glaucoma.

Its Minimally Invasive Micro Sclerostomy (MIMS) solution consists of a single-patient-use sterile tool and a multi-use external machine.

In the course of the surgery, a sclero-corneal drainage channel is created to reduce intraocular pressure.MIMS is a microfluidic full-thickness procedure developed as an advanced laser sclerostomy.

The technique uses a cutting and drilling device to reduce trauma to the surrounding tissue, minimizing scar tissue formation and allowing for a long-lasting filtering bleb.

The MIMS channel ensures a controlled fluid flow with minor complications.In March 2017, Sanoculis was granted CE marking for its MIMS device and procedure.